Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Capillary Biomedical logo — company profile

Capillary Biomedical

Founded 2014 United States Irvine, United States 10 employees Debt Financing Total: $4.49M Biotechnology, Health Care +1

General Information

Company Name Capillary Biomedical
Founded Year 2014
Location United States Irvine, United States
Employees 10
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Capillary Biomedical. To contact Capillary Biomedical, visit capillarybio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Capillary Biomedical compare?

A PDF of Capillary Biomedical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Capillary Biomedical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Capillary Biomedical

Capillary Biomedical is a biotechnology and health care startup founded in 2014, based in Irvine, CA. The company's mission is to simplify insulin delivery and alleviate the burden on patients and the healthcare system. Their flagship product, the patent-pending SteadiSet infusion set for insulin pump therapy, features SteadiFlow technology, which incorporates a kink-proof, super-soft cannula with multi-port delivery for comfortable and reliable insulin delivery. CapBio's user-friendly insertion device is designed to make the process easy for patients. The startup, which is a spin-out of the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA, collaborates with academic institutions to improve the comfort, reliability, and predictability of insulin infusion therapy. Their goal is to achieve more consistent and reliable insulin absorption, resulting in improved blood glucose control for people with diabetes. Capillary Biomedical recently received a $1.50M debt financing investment on 07 October 2020 from The Leona M. and Harry B. Helmsley Charitable Trust. This funding will likely contribute to the company's development efforts and further advancement in the field of diabetes management technology.

Business keywords: diabetes management, insulin delivery, glucose monitoring, medical innovation, startup, biomedical technology, artificial pancreas, innovation spin-out, academic-industry collaboration, predictive medicine, Irvine, CA, Thomas Jefferson University, Sidney Kimmel Medical College

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $1.50M 1
The Leona M. and Harry B. Helmsley Charitable Trust
07 Oct 2020
Private Equity Round Undisclosed 2
Tech Coast Angels East Los Capital
Tech Coast Angels, East Los Capital
01 Oct 2019
Seed Round $2.89M 7
New York Angels T1D Fund HBS Alumni Angels
New York Angels, T1D Fund +5
14 Aug 2018
Seed Round Undisclosed -
01 Jan 2016
Seed Round $100.00K -
06 May 2014

Capillary Biomedical Alternatives & Competitors

View All Alternatives
Capillary Biomedical vs
Bigfoot Biomedical
Bigfoot Biomedical United States

A Simple Way To Manage Diabetes

Convertible Note
80 employees
AI, Analytics
Compare Capillary Biomedical vs Bigfoot Biomedical
Capillary Biomedical vs
Medtrum Technologies Inc.
Medtrum Technologies Inc. China

Simplifying Diabetes

Series C
28 employees
Biotechnology, Health Care
Capillary Biomedical vs
NIQS Tech
NIQS Tech United Kingdom

Glucose Insights, Smarter Living

Seed
4 employees
Health Care, Medical Devices
View all alternatives

FAQ About Capillary Biomedical

Capillary Biomedical, Inc. (CapBio) is a medical device startup developing technologies for diabetes management. We aim to dramatically simplify insulin delivery, reducing the burden on both patients and the overall healthcare system. CapBio's first product is the patent-pending SteadiSet infusion...
Capillary Biomedical was founded in 2014.
Capillary Biomedical is headquartered in Irvine, United States.
Capillary Biomedical operates in Biotechnology, Health Care and Medical Devices. Its work centres on diabetes management, insulin delivery, glucose monitoring and medical innovation.
Capillary Biomedical has approximately 10 employees.
Capillary Biomedical has completed 5 funding rounds, raising a total of $4.49M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Capillary Biomedical include Bigfoot Biomedical, Medtrum Technologies Inc., NIQS Tech, Beta Bionics, Apollon. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Capillary Biomedical and Bigfoot Biomedical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Capillary Biomedical, https://bouncewatch.com/company/capillary-biomedical, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes